Related Experiment Video
Updated: Jun 10, 2026
11:52
Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
Overview of the Final MEIC Results: I. The In Vitro--In Vitro Evaluation
1CTLU, Pavals, När, SE-620 13, Stånga, Sweden.
Summary
In vitro toxicity testing shows high similarity across methods, driven by cell types and viability endpoints. Differences arise from exposure times and test object diversity, supporting basal cytotoxicity concepts for improved testing.
Area of Science:
- Toxicology
- In Vitro Assays
- Chemical Safety
Background:
- The Multicenter Evaluation of In Vitro Cytotoxicity (MEIC) study evaluated numerous in vitro toxicity assays.
- Understanding the performance and variability of these assays is crucial for reliable toxicity testing.
- Previous analyses compared subsets of MEIC data to identify factors influencing assay results.
Purpose of the Study:
- To analyze the performance of 61 in vitro toxicity assays using all 50 MEIC reference chemicals.
- To identify key methodological factors contributing to similarity and dissimilarity in assay outcomes.
- To provide insights for improving future in vitro toxicity testing strategies and support the basal cytotoxicity concept.
Main Methods:
- Principal Component Analysis (PCA) was used to assess the overall similarity of results from 61 in vitro assays.
- A 'random probe' analysis, employing linear regression, systematically compared assay pairs differing in specific methodological factors.
- The analysis examined factors including cell type, viability endpoints, exposure times, and test object phylogeny.
Main Results:
- PCA indicated a high general similarity (approximately 80%) among the results from the 61 tested in vitro methods.
- Assays with different cell types (mean R(2) 0.81) and viability endpoints (mean R(2) 0.85) showed strong correlation, explaining much of the similarity.
- Dissimilarity (20%) was primarily linked to variations in exposure times and the use of phylogenetically distant organisms in ecotoxicological assays.
Conclusions:
- The findings support the basal cytotoxicity concept, suggesting a common mechanism of toxicity across diverse assays.
- Simple cell line assays may be suitable replacements for complex primary cultures in many screening applications.
- Future in vitro toxicity testing should consider incorporating assays with varied exposure times for comprehensive evaluation.
Related Concept Videos
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:17Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
01:20Drug Product Performance: In Vitro–In Vivo Correlation
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:13In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...